Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Merit Medical Systems, Inc. (MMSI) PT Lowered to $73 at Needham & Company
February 25, 2022 6:33 AM ESTNeedham & Company analyst Mike Matson lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $73.00 (from $83.00) while maintaining a Buy rating.
The analyst commented, "MMSI's 4Q21 revenue and EPS beat consensus. Revenue growth slowed slightly to 8.4% Y/Y in 4Q21 from 8.8%... More
Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 19c, Offers Guidance
February 24, 2022 4:43 PM ESTMerit Medical Systems Inc. (NASDAQ: MMSI) reported Q4 EPS of $0.71, $0.19 better than the analyst estimate of $0.52. Revenue for the quarter came in at $278.5 million versus the consensus estimate of $271.49 million.
GUIDANCE:
Merit Medical Systems Inc. sees FY2022 EPS of... More
